To determine whether EGF is acting through EGFR or a secondary target, exogenous EGFR was overexpressed in both HNSCC cell lines in the presence of serum and exposed to either 0 or 20 ng/ml EGF ligand. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.